Dasatinib: A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1771-1795

Adis International

Access to resources Recommend Favorite

Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome–positive acute lymphoblastic leukemia

By Shimoni Avichai   Volchek Yulia   Koren-Michowitz Maya   Varda-Bloom Nira   Somech Raz   Shem-Tov Noga   Yerushalmi Ronit   Nagler Arnon  

Cancer, Vol. 121, Iss. 6, 2015-03 ,pp. : 863-871

Blackwell Publishing

Access to resources Recommend Favorite

Dasatinib for the treatment of Philadelphia chromosome-positive leukemias

By Santos Fabio P S   Cortes Jorge  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2381-2395

Informa Healthcare

Access to resources Recommend Favorite

A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia

By Carpiuc Kimbach T   Stephens Jennifer M   Botteman Marc F   Feng Weiwei   Hay Joel W  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2775-2787

Informa Healthcare

Access to resources Recommend Favorite

Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia

By Jeha Sima   Coustan-Smith Elaine   Pei Deqing   Sandlund John T.   Rubnitz Jeffrey E.   Howard Scott C.   Inaba Hiroto   Bhojwani Deepa   Metzger Monika L.   Cheng Cheng   Choi John K.   Jacobsen Jeffrey   Shurtleff Sheila A.   Raimondi Susana   Ribeiro Raul C.   Pui Ching-Hon   Campana Dario  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1514-1519

Blackwell Publishing

Access to resources Recommend Favorite